Printer Friendly

Adrienne R. Takacs senior director, Lilly Research Laboratories Operations.

Adrienne R. Takacs, Ph.D. joined Lilly Research Laboratories in 2000 as Senior Director of Drug Disposition with a primary focus on ADME, metabolism and bioanalytical capabilities in support of the development and discovery of LRUs molecule portfolio.

She began her post-doctoral career in pharmaceutical research as a Senior Scientist at Hoffman-LaRoche, Inc. in 1986. She continued her pharmaceutical research career at Ciba-Geigy, where she initiated and led the paradigm of early discovery intervention by ADME. She spent nine years, from 1991 until 2000, at R.W. Johnson Pharmaceutical Research Institute, progressing to increasing levels of responsibility in scientific management. She directed the Drug Disposition component, including ADME and PK/PD, in support of discovery and development of small and large NMEs.

Dr. Takacs received her B.S. degree in Biology from Ithaca College in 1977. Following both academic and pharmaceutical research positions, she obtained her Ph.D. in Pharmacology from the University of Kentucky in 1985. Her research focused on hepatic transport mechanisms of organic anions. Dr. Takacs is a Six Sigma Green Belt and has led a number of initiatives to improve R&D productivity.

COPYRIGHT 2011 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MEET THE SPEAKERS
Publication:Contract Pharma
Date:Sep 1, 2011
Words:187
Previous Article:Bruce D. Naumann senior principal scientist, director of occupational and environmental toxicology, Merck.
Next Article:Executive outsourcing summit.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters